SLC19A1 pharmacogenomics summary

Pharmacogenet Genomics. 2010 Nov;20(11):708-15. doi: 10.1097/FPC.0b013e32833eca92.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / blood
  • Antimetabolites, Antineoplastic / metabolism
  • Cricetinae
  • Cricetulus
  • Humans
  • Methotrexate / adverse effects
  • Methotrexate / blood
  • Methotrexate / metabolism
  • Mice
  • Pharmacogenetics
  • Reduced Folate Carrier Protein / genetics*

Substances

  • Antimetabolites, Antineoplastic
  • Reduced Folate Carrier Protein
  • SLC19A1 protein, human
  • Methotrexate